Physician profile
Amit Grover
NPI 1801028451
$8,422.21
in general payments reported to CMS, 2019-2025
9 companies · $2,208 in 2025
The $2,208 reported for 2025 was more than what 87% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $194 · 2023: $887 · 2024: $5,009 · 2025: $2,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,670 · Food and Beverage: $2,218 · Travel and Lodging: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,670.00 |
| Food and Beverage | $2,217.99 |
| Travel and Lodging | $216.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $6,519.64 | 2022-2025 | Fujifilm |
| Boston Scientific Corporation | $1,434.93 | 2021-2025 | Cre Pro, Orbera Intragastric Balloon System, Apollo Esg System |
| Echosens North America, INC. | $135.06 | 2025 | Fibroscan |
| Cook Medical LLC | $116.91 | 2023 | Echotip, Instinct |
| Novo Nordisk INC | $73.63 | 2023-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $68.15 | 2022-2023 | Eliquis |
| Pfizer INC. | $34.30 | 2023 | |
| Csl Behring | $22.38 | 2023 | Haegarda |
| Abbott Laboratories | $17.21 | 2025 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Grover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.